|
PPM1D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.44009948200141E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.20199999953385E-07 |
| Normal-vs-Stage2 |
8.631800E-04 |
| Normal-vs-Stage3 |
1.89219995228029E-09 |
| Normal-vs-Stage4 |
4.61940041773801E-10 |
| Stage1-vs-Stage2 |
6.110200E-01 |
| Stage1-vs-Stage3 |
2.700400E-02 |
| Stage1-vs-Stage4 |
1.295670E-03 |
| Stage2-vs-Stage3 |
5.330100E-02 |
| Stage2-vs-Stage4 |
3.579300E-03 |
| Stage3-vs-Stage4 |
1.496390E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.6089000393934E-09 |
| Normal-vs-AfricanAmerican |
9.813600E-04 |
| Normal-vs-Asian |
1.77238999999885E-05 |
| Caucasian-vs-AfricanAmerican |
9.326400E-01 |
| Caucasian-vs-Asian |
8.943800E-01 |
| AfricanAmerican-vs-Asian |
8.641800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.63479995996374E-09 |
| Normal-vs-Female |
5.79879999573762E-09 |
| Male-vs-Female |
3.117400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.19780000002101E-06 |
| Normal-vs-Age(41-60Yrs) |
4.59439997158029E-09 |
| Normal-vs-Age(61-80Yrs) |
4.06239997197133E-09 |
| Normal-vs-Age(81-100Yrs) |
1.098310E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.358400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.400500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.377770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.046600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.432400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.549600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.15739999987319E-07 |
| Classical-VS-Follicular |
2.041800E-02 |
| Classical-VS-Other |
8.115000E-01 |
| Classical-VS-Normal |
4.21580000020683E-07 |
| Tall-VS-Follicular |
1.748140E-02 |
| Tall-VS-Other |
2.063600E-01 |
| Tall-VS-Normal |
2.75649503223008E-11 |
| Follicular-VS-Other |
6.070800E-01 |
| Follicular-VS-Normal |
2.87820000055561E-08 |
| Other-VS-Normal |
5.231800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.64369997799486E-09 |
| Normal-vs-N1 |
2.20589999999632E-06 |
| N0-vs-N1 |
5.014400E-01 |
|
|
